Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The Effect of Calcium on Activity, Immunogenicity and Efficacy of a Recombinant N1/N2 Neuraminidase Vaccine

ABSTRACT: The Effect of Calcium on Activity, Immunogenicity and Efficacy of a Recombinant N1/N2 Neuraminidase Vaccine

PROVIDER: PRJNA671601 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

The Effect of Calcium on Activity, Immunogenicity and Efficacy of a Recombinant N1/N2 Neuraminidase Vaccine

Project description:Despite the importance of immunity against neuraminidase (NA), NA content and immunogenicity is neglected in current influenza vaccines. To address this, a novel recombinant N1/N2 NA vaccine (NAV) was developed. Stability assays were used to determine optimal temperature and buffer conditions for vaccine storage. The effect of calcium-related enhancement of NA stability and activity on N1 and N2 immunogenicity and efficacy against viral challenge was assessed. Differences in activity between N1 and N2 and calcium-related activity enhancement did not translate into differences in immunogenicity or efficacy. NAV vaccinated mice showed robust antibody titers against N1 and N2, decreased viral titers, and decreased antiviral and inflammatory responses by transcriptomic analysis.

2021-03-30 | GSE160010 | GEO

The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine.

Project description:Despite the importance of immunity against neuraminidase (NA), NA content and immunogenicity are neglected in current influenza vaccines. To address this, a recombinant N1/N2 NA vaccine (NAV) was developed. Stability assays were used to determine optimal temperature and buffer conditions for vaccine storage. The effect of divalent cation-related enhancement of NA stability and activity on N1 and N2 immunogenicity and efficacy against viral challenge was assessed. Differences in activity between N1 and N2 and cation-related activity enhancement did not translate into differences in immunogenicity or efficacy. NAV-vaccinated mice showed robust antibody titers against N1 and N2, and after challenge with influenza A (H1N1) virus, decreased viral titers and decreased antiviral and inflammatory responses by transcriptomic analysis. These findings provide guidance for optimal storage and assessment of NA-based vaccines and confirm the importance of NA in influenza vaccination strategies in attenuating viral replication and limiting inflammatory responses necessary to clear infection.

| S-EPMC8024250 | biostudies-literature

Detoxins S1, N1, N2, N3, P1, P2, P3 source strain raw UHPLC-MS data and representative MS2

Project description:detoxin S1 source strain Streptomyces sp. S-325 (JOIW01) raw UHPLC-MS data and representative MS2 detoxins N1, N2, N3 source strain Streptomyces spectabilis NRRL 2792 raw UHPLC-MS data and representative MS2 detoxins N2, N3 source strain Streptomyces sp. NRRL B-1347 (JOJM01) raw UHPLC-MS data detoxins P1, P2, P3 source strain Amycolatopsis jujuensis NRRL B-24427 raw UHPLC-MS data and representative MS2

2019-04-01 | MSV000083648 | MassIVE

Mrgpra1 controls neutrophil hyperactivation by balancing N1/N2 switch

Project description:Mrgpra1 controls neutrophil hyperactivation by balancing N1/N2 switch

| PRJNA823687 | ENA

N1-methylpseudouridine found within COVID-19 mRNA vaccines produces faithful protein products

Project description:The COVID mRNA vaccines utilize the modified nucleobase N1-methylpseudouridine, in place of canonical uridine, to improve immunogenicity and protein yield. However, relatively few studies have investigated the effect of modified nucleobases on the fidelity of protein translation. Given the interest in the COVID mRNA vaccines, we sought to investigate how N1-methylpseudouridine (and the related modification pseudouridine) is read by ribosomes.

2022-08-18 | PXD029291 | Pride

RNA-seq of mouse neutrophils polarized to proinflammatory N1 by lipopolysaccharide and interferon-γ or anti-inflammatory N2 by interleukin-4 versus control

Project description:Gene expression profiling for mouse N1 and N2 neutrophils. Neutrphils were isolated form the bone marrow of C57BL/6J mice between 12-16 weeks old. Approximately 8x10^7 neutrophils were used per condition and were split into 3 biological replicates. Freshly isolated neutrophils were cultured for 2h in RPMI medium, in the presence of 100 ng/ml lipopolysaccharide (LPS) and 20 ng/ml interferon gamma (IFNγ) or 20 ng/ml interleukin 4 (IL-4). Total RNA was isolated with TRIzol reagent and Phasemaker tubes. A sample from the LPS+IFNγ polarization did not pass the quality control test and was excluded from the downstream analysis.

2021-07-29 | E-MTAB-10508 | biostudies-arrayexpress

E1,E2,E3,N1,N2,N3,S1,S2,S3,W1,W2,W3

Project description:E1,E2,E3,N1,N2,N3,S1,S2,S3,W1,W2,W3 Raw sequence reads

| PRJNA1100265 | ENA

E1,E2,E3,N1,N2,N3,S1,S2,S3,W1,W2,W3

Project description:E1,E2,E3,N1,N2,N3,S1,S2,S3,W1,W2,W3 Raw sequence reads

| PRJNA1101590 | ENA

Altererythrobacter sp. N1 strain:N1

Project description:Altererythrobacter sp. N1 strain:N1 Genome sequencing

| PRJNA764449 | ENA

Nitrobacter sp. N1 strain:N1

Project description:Nitrobacter sp. N1 strain:N1 Genome sequencing